Control of cross talk between angiogenesis and inflammation by mesenchymal stem cells for the treatment of ocular surface diseases

Stem Cells International

Volumn 2016, Issue , 2016, Pages

  Li, Fei ^a   Zhao, Shao Zhen ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ANTIINFLAMMATORY ACTIVITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL INFILTRATION; CELL LOSS; CLINICAL EFFECTIVENESS; CORNEA TRANSPLANTATION; DISEASE ASSOCIATION; DRY EYE; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OCULAR SURFACE DISEASE; PATIENT SAFETY; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; WOUND HEALING;

EID: 84964874578     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2016/7961816     Document Type: Review

References (100)

1. H. S. Dua and A. Azuara-Blanco, "Limbal stem cells of the corneal epithelium, " Survey of Ophthalmology, vol. 44, no. 5, pp. 415-425, 2000.
2. G. Pellegrini, P. Rama, F. Mavilio, and M. De Luca, "Epithelial stem cells in corneal regeneration and epidermal gene therapy, " Journal of Pathology, vol. 217, no. 2, pp. 217-228, 2009.
3. J. B. Jonas, R. M. Rank, and W. M. Budde, "Immunologic graft reactions after allogenic penetrating keratoplasty, " American Journal of Ophthalmology, vol. 133, no. 4, pp. 437-443, 2002.
4. K. Inoue, S. Amano, T. Oshika, and T. Tsuru, "Risk factors for corneal graft failure and rejection in penetrating keratoplasty, " Acta Ophthalmologica Scandinavica, vol. 79, no. 3, pp. 251-255, 2001.
5. R. W. Thompson Jr., M. O. Price, P. J. Bowers, and F. W. Price Jr., "Long-term graft survival after penetrating keratoplasty, " Ophthalmology, vol. 110, no. 7, pp. 1396-1402, 2003.
6. J. P. Whitcher, M. Srinivasan, and M. P. Upadhyay, "Corneal blindness: a global perspective, " Bulletin of the World Health Organization, vol. 79, no. 3, pp. 214-221, 2001.
7. P. Bianco, P. G. Robey, and P. J. Simmons, "Mesenchymal stem cells: revisiting history, concepts, and assays, " Cell Stem Cell, vol. 2, no. 4, pp. 313-319, 2008.
8. W. R. Otto and N. A. Wright, "Mesenchymal stem cells: from experiment to clinic, " Fibrogenesis and Tissue Repair, vol. 4, no. 1, article 20, 2011.
9. A. Uccelli, L. Moretta, and V. Pistoia, "Mesenchymal stem cells in health and disease, " Nature Reviews Immunology, vol. 8, no. 9, pp. 726-736, 2008.
10. N. Hu, Y.-Y. Zhang, H.-W. Gu, and H.-J. Guan, "Effects of bone marrow mesenchymal stem cells on cell proliferation and growth factor expression of limbal epithelial cells in vitro, " Ophthalmic Research, vol. 48, no. 2, pp. 82-88, 2012.
11. H. K. Salem and C. Thiemermann, "Mesenchymal stromal cells: current understanding and clinical status, " STEM CELLS, vol. 28, no. 3, pp. 585-596, 2010.
12. M. F. Pittenger, A. M. Mackay, S. C. Beck, et al., "Multilineage potential of adult human mesenchymal stem cells, " Science, vol. 284, no. 5411, pp. 143-147, 1999.
13. L. Da Silva Meirelles, P. C. Chagastelles, and N. B. Nardi, "Mesenchymal stem cells reside in virtually all post-natal organs and tissues, " Journal of Cell Science, vol. 119, no. 11, pp. 2204-2213, 2006.
14. M. Crisan, S. Yap, L. Casteilla, et al., "A Perivascular origin for mesenchymal stem cells in multiple human organs, " Cell Stem Cell, vol. 3, no. 3, pp. 301-313, 2008.
15. M. Crisan, S. Yap, L. Casteilla, et al., "A perivascular origin for mesenchymal stem cells in multiple human organs, " Cell Stem Cell, vol. 3, no. 3, pp. 301-313, 2008.
16. M. Crisan, C.-W. Chen, M. Corselli, G. Andriolo, L. Lazzari, and B. Peault, "Perivascular multipotent progenitor cells in human organs, " Annals of the New York Academy of Sciences, vol. 1176, pp. 118-123, 2009.
17. M. Dominici, K. Le Blanc, I. Mueller, et al., "Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement, " Cytotherapy, vol. 8, no. 4, pp. 315-317, 2006.
18. F. Alviano, V. Fossati, C. Marchionni, et al., "Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro, " BMC Developmental Biology, vol. 7, article 11, 2007.
19. P. Cipriani, S. Guiducci, I. Miniati, et al., "Impairment of endothelial cell differentiation frombonemarrow-derivedmesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis, " Arthritis and Rheumatism, vol. 56, no. 6, pp. 1994-2004, 2007.
20. V. Paunescu, E. Deak, D. Herman, et al., "In vitro differentiation of humanmesenchymal stem cells to epithelial lineage, " Journal of Cellular and Molecular Medicine, vol. 11, no. 3, pp. 502-508, 2007.
21. S. Gu, C. Xing, J. Han, M. O. M. Tso, and J. Hong, "Differentiation of rabbit bonemarrowmesenchymal stem cells into corneal epithelial cells in vivo and ex vivo, "Molecular Vision, vol. 15, pp. 99-107, 2009.
22. E. M. Martinez-Conesa, E. Espel, M. Reina, and R. P. Casaroli-Marano, "Characterization of ocular surface epithelial and progenitor cell markers in human adipose stromal cells derived from lipoaspirates, " Investigative Opthalmology & Visual Science, vol. 53, no. 1, pp. 513-520, 2012.
23. H. Liu, J. Zhang, C.-Y. Liu, Y. Hayashi, and W. W.-Y. Kao, "Bone marrow mesenchymal stem cells can differentiate and assume corneal keratocyte phenotype, " Journal of Cellular and Molecular Medicine, vol. 16, no. 5, pp. 1114-1124, 2012.
24. H. Liu, J. Zhang, C.-Y. Liu, et al., "Cell therapy of congenital corneal diseases with umbilical mesenchymal stem cells: lumican null mice, " PLoS ONE, vol. 5, no. 5, Article ID e10707, 2010.
25. M. Nakahara, N. Okumura, E. P. Kay, et al., "Corneal endothelial expansion promoted by human bone marrow mesenchymal stem cell-derived conditioned medium, " PLoS ONE, vol. 8, no. 7, Article ID e69009, 2013.
26. D. G. Phinney and D. J. Prockop, "Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views, " STEMCELLS, vol. 25, no. 11, pp. 2896-2902, 2007.
27. J. Galipeau, "The mesenchymal stromal cells dilemma-does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?" Cytotherapy, vol. 15, no. 1, pp. 2-8, 2013.
28. J. Lei, D. Hui, W. Huang, et al., "Heterogeneity of the biological properties and gene expression profiles ofmurine bone marrow stromal cells, " International Journal of Biochemistry and Cell Biology, vol. 45, no. 11, pp. 2431-2443, 2013.
29. M. Krampera, L. Cosmi, R. Angeli, et al., "Role for interferon-γ in the immunomodulatory activity of human bone marrow mesenchymal stem cells, " Stem Cells, vol. 24, no. 2, pp. 386-398, 2006.
30. G. Ren, J. Su, L. Zhang, et al., "Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression, " Stem Cells, vol. 27, no. 8, pp. 1954-1962, 2009.
31. X. Zhang, C. Jiao, and S. Zhao, "Role of mesenchymal stem cells in immunological rejection of organ transplantation, " Stem Cell Reviews and Reports, vol. 5, no. 4, pp. 402-409, 2009.
32. S. Aggarwal and M. F. Pittenger, "Human mesenchymal stem cells modulate allogeneic immune cell responses, " Blood, vol. 105, no. 4, pp. 1815-1822, 2005.
33. M. M. Duffy, T. Ritter, R. Ceredig, and M. D. Griffin, "Mesenchymal stemcell effects onT-cell effector pathways, " StemCell Research andTherapy, vol. 2, no. 4, article 34, 2011.
34. E. Soleymaninejadian, K. Pramanik, and E. Samadian, "Immunomodulatory properties of mesenchymal stem cells: cytokines and factors, " American Journal of Reproductive Immunology, vol. 67, no. 1, pp. 1-8, 2012.
35. E. J. Bassi, D. C. de Almeida, P. M. M. Moraes-Vieira, and N. O. S. Camara, "Exploring the role of soluble factors associated with immune regulatory properties ofmesenchymal stem cells, " Stem Cell Reviews and Reports, vol. 8, no. 2, pp. 329342, 2012.
36. F. Baratelli, Y. Lin, L. Zhu, et al., "Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells, " The Journal of Immunology, vol. 175, no. 3, pp. 1483-1490, 2005.
37. K. English, J. M. Ryan, L. Tobin, M. J. Murphy, F. P. Barry, and B. P. Mahon, "Cell contact, prostaglandin E2 and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25High forkhead box P3+ regulatory T cells, " Clinical & Experimental Immunology, vol. 156, no. 1, pp. 149-160, 2009.
38. F. Casiraghi, N. Perico, and G. Remuzzi, "Mesenchymal stromal cells to promote solid organ transplantation tolerance, " Current Opinion in Organ Transplantation, vol. 18, no. 1, pp. 51-58, 2013.
39. G. D. Wu, J. A. Nolta, Y.-S. Jin, et al., "Migration ofmesenchymal stem cells to heart allografts during chronic rejection, " Transplantation, vol. 75, no. 5, pp. 679-685, 2003.
40. S. Itakura, S. Asari, J. Rawson, et al., "Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat, " American Journal of Transplantation, vol. 7, no. 2, pp. 336-346, 2007.
41. W. Ge, J. Jiang, J. Arp, W. Liu, B. Garcia, and H. Wang, "Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2, 3-dioxygenase expression, " Transplantation, vol. 90, no. 12, pp. 1312-1320, 2010.
42. C. D. Wan, R. Cheng, H. B. Wang, and T. Liu, "Immunomodulatory effects of mesenchymal stem cells derived from adipose tissues in a rat orthotopic livertransplantation model, " Hepatobiliary & Pancreatic Diseases International, vol. 7, no. 1, pp. 29-33, 2008.
43. J. Gao, J. E. Dennis, R. F. Muzic, M. Lundberg, and A. I. Caplan, "The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion, " Cells Tissues Organs, vol. 169, no. 1, pp. 12-20, 2001.
44. Y. Wu and R. C. Zhao, "The role of chemokines inmesenchymal stem cell homing to myocardium, " Stem Cell Reviews and Reports, vol. 8, no. 1, pp. 243-250, 2012.
45. H. M. Hatch, D. Zheng, M. L. Jorgensen, and B. E. Petersen, "SDF-1α/CXCR4: a mechanism for hepatic oval cell activation and bone marrow stem cell recruitment to the injured liver of rats, " Cloning and Stem Cells, vol. 4, no. 4, pp. 339-351, 2002.
46. R. F. Wynn, C. A. Hart, C. Corradi-Perini, et al., "Asmall proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promotingmigration to bone marrow, " Blood, vol. 104, no. 9, pp. 2643-2645, 2004.
47. E. Chavakis, C. Urbich, and S. Dimmeler, "Homing and engraftment of progenitor cells: a prerequisite for cell therapy, " Journal ofMolecular and Cellular Cardiology, vol. 45, no. 4, pp. 514-522, 2008.
48. J. Ye, K. Yao, and J. C. Kim, "Mesenchymal stem cell transplantation in a rabbit corneal alkali burn model: engraftment and involvement in wound healing, " Eye, vol. 20, no. 4, pp. 482-490, 2006.
49. G. W. Roddy, J. Y. Oh, R. H. Lee, et al., "Action at a distance: systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-α stimulated gene/protein 6, " Stem Cells, vol. 29, no. 10, pp. 1572-1579, 2011.
50. S. H. Park, K. W. Kim, Y. S. Chun, and J. C. Kim, "Human mesenchymal stem cells differentiate into keratocyte-like cells in keratocyte-conditioned medium, " Experimental Eye Research, vol. 101, pp. 16-26, 2012.
51. J. Cejkova, P. Trosan, C. Cejka, et al., "Suppression of alkaliinduced oxidative injury in the cornea by mesenchymal stem cells growing on nanofiber scaffolds and transferred onto the damaged corneal surface, " Experimental Eye Research, vol. 116, pp. 312-323, 2013.
52. J. Y. Oh, R. H. Lee, J. M. Yu, et al., "Intravenous mesenchymal stem cells prevented rejection of allogeneic corneal transplants by aborting the early inflammatory response, " Molecular Therapy, vol. 20, no. 11, pp. 2143-2152, 2012.
53. Z. Jia, C. Jiao, S. Zhao, et al., "Immunomodulatory effects of mesenchymal stem cells in a rat corneal allograft rejection model, " Experimental Eye Research, vol. 102, pp. 44-49, 2012.
54. O. Treacy, L. O'Flynn, A. E. Ryan, et al., "Mesenchymal stem cell therapy promotes corneal allograft survival in rats by local and systemic immunomodulation, " American Journal of Transplantation, vol. 14, no. 9, pp. 2023-2036, 2014.
55. M. J. Lee, A. Y. Ko, J. H. Ko, et al., "Mesenchymal stem/stromal cells protect the ocular surface by suppressing inflammation in an experimental dry eye, " Molecular Therapy, vol. 23, no. 1, pp. 139-146, 2015.
56. J. Weng, C. He, P. Lai, et al., "Mesenchymal stromal cells treatment attenuates dry eye in patients with chronic graftversus-host disease, " Molecular Therapy, vol. 20, no. 12, pp. 2347-2354, 2012.
57. S. Inoue, F. C. Popp, G. E. Koehl, et al., "Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model, " Transplantation, vol. 81, no. 11, pp. 1589-1595, 2006.
58. E. Y. Lee, Y. Xia, W.-S. Kim, et al., "Hypoxia-enhanced woundhealing function of adipose-derived stem cells: increase in stem cell proliferation and up-regulation ofVEGF and bFGF, " Wound Repair and Regeneration, vol. 17, no. 4, pp. 540-547, 2009.
59. T. J. Cashman, V. Gouon-Evans, and K. D. Costa, "Mesenchymal stem cells for cardiac therapy: practical challenges and potential mechanisms, " Stem Cell Reviews and Reports, vol. 9, no. 3, pp. 254-265, 2013.
60. A. M. Abarbanell, Y. Wang, J. L. Herrmann, et al., "Toll-like receptor 2 mediates mesenchymal stemcell-associatedmyocardial recovery and VEGF production following acute ischemiareperfusion injury, "The American Journal of Physiology-Heart and Circulatory Physiology, vol. 298, no. 5, pp. H1529-H1536, 2010.
61. W. M. Jackson, L. J. Nesti, and R. S. Tuan, "Concise review: clinical translation of wound healing therapies based on mesenchymal stem cells, " Stem Cells Translational Medicine, vol. 1, no. 1, pp. 44-50, 2012.
62. L. Yao, Z.-R. Li, W.-R. Su, et al., "Role of mesenchymal stemcells on cornea wound healing induced by acute alkali burn, " PLoS ONE, vol. 7, no. 2, Article ID e30842, 2012.
63. J. Y. Oh, M. K. Kim, M. S. Shin, et al., "The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury, " Stem Cells, vol. 26, no. 4, pp. 1047-1055, 2008.
64. V. Holan and E. Javorkova, "Mesenchymal stem cells, nanofiber scaffolds and ocular surface reconstruction, " Stem Cell Reviews and Reports, vol. 9, no. 5, pp. 609-619, 2013.
65. H. Reinshagen, C. Auw-Haedrich, R. V. Sorg, et al., "Corneal surface reconstruction using adult mesenchymal stem cells in experimental limbal stem cell deficiency in rabbits, " Acta Ophthalmologica, vol. 89, no. 8, pp. 741-748, 2011.
66. L. Liang, H. Sheha, J. Li, and S. C. G. Tseng, "Limbal stem cell transplantation: newprogresses and challenges, " Eye, vol. 23, no. 10, pp. 1946-1953, 2009.
67. M. Eslani, A. Baradaran-Rafii, A. Movahedan, and A. R. Djalilian, "The ocular surface chemical burns, " Journal of Ophthalmology, vol. 2014, Article ID 196827, 9 pages, 2014.
68. Y. Lan, S. Kodati, H. S. Lee, M. Omoto, Y. Jin, and S. K. Chauhan, "Kinetics and function of mesenchymal stem cells in corneal injury, " Investigative Ophthalmology and Visual Science, vol. 53, no. 7, pp. 3638-3644, 2012.
69. J. Y. Oh, J. H. Ko, M. K. Kim, and W. R. Wee, "Effects of mesenchymal stem/stromal cells on cultures of corneal epithelial progenitor cells with ethanol injury, " Investigative Opthalmology & Visual Science, vol. 55, no. 11, pp. 7628-7635, 2014.
70. J. Y. Oh, M. K. Kim, M. S. Shin, et al., "The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury, " STEM CELLS, vol. 26, no. 4, pp. 1047-1055, 2008.
71. Y. Ma, Y. Xu, Z. Xiao, et al., "Reconstruction of chemically burned rat corneal surface by bone marrow-derived human mesenchymal stem cells, " Stem Cells, vol. 24, no. 2, pp. 315-321, 2006.
72. A. Zajicova, K. Pokorna, A. Lencova, et al., "Treatment of ocular surface injuries by limbal and mesenchymal stem cells growing on nanofiber scaffolds, " Cell Transplantation, vol. 19, no. 10, pp. 1281-1290, 2010.
73. J. Y. Lee, H. J. Jeong, M. K. Kim, and W. R. Wee, "Bone marrowderivedmesenchymal stem cells affect immunologic profiling of interleukin-17-secreting cells in a chemical burn mousemodel, " Korean Journal of Ophthalmology, vol. 28, no. 3, pp. 246-256, 2014.
74. J. Y. Oh, G. W. Roddy, H. Choi, et al., "Anti-inflammatoryprotein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 39, pp. 16875-16880, 2010.
75. K. Cunnusamy, P. W. Chen, and J. Y. Niederkorn, "Paradigm shifts in the role of CD4+ T cells in keratoplasty, " Discovery Medicine, vol. 10, no. 54, pp. 452-461, 2010.
76. J. Y. Niederkorn and D. F. Larkin, "Immune privilege of corneal allografts, " Ocular Immunology and Inflammation, vol. 18, no. 3, pp. 162-171, 2010.
77. E. Chong and M. R. Dana, "Graft failure IV. Immunologic mechanisms of corneal transplant rejection, " International Ophthalmology, vol. 28, no. 3, pp. 209-222, 2008.
78. J. Y. Niederkorn, "High-risk corneal allografts andwhy they lose their immune privilege, " CurrentOpinion in Allergy and Clinical Immunology, vol. 10, no. 5, pp. 493-497, 2010.
79. A. Poon, M. Constantinou, E. Lamoureux, and H. R. Taylor, "Topical Cyclosporin A in the treatment of acute graft rejection: a randomized controlled trial, " Clinical and Experimental Ophthalmology, vol. 36, no. 5, pp. 415-421, 2008.
80. Y. Liu, J. Jiang, H. Xiao, et al., "Topical application of FTY720 and cyclosporinAprolong corneal graft survival inmice, "Molecular Vision, vol. 18, pp. 624-633, 2012.
81. J. Yuan, J. J. Zhai, X. Huang, S. Y. Zhou, and J. Q. Chen, "Ocular safety and pharmacokinetics study of FK506 suspension eye drops after corneal transplantation, " Journal of Ocular Pharmacology andTherapeutics, vol. 28, no. 2, pp. 153-158, 2012.
82. A. A. Zaki, M. S. Elalfy, D. G. Said, and H. S. Dua, "Deepanterior lamellar keratoplasty-triple procedure: a useful clinical application of the pre-Descemets layer (Duas layer), " Eye, vol. 29, no. 3, pp. 323-326, 2015.
83. S. M. Pantanelli, A. Herzlich, G. Yeaney, and S. T. Ching, "Recurrence of granular corneal dystrophy type I deposits within host stroma after non-Descemet baring anterior lamellar keratoplasty, " Cornea, vol. 33, no. 12, pp. 1348-1351, 2014.
84. G. S. L. Peh, R. W. Beuerman, A. Colman, D. T. Tan, and J. S. Mehta, "Human corneal endothelial cell expansion for corneal endothelium transplantation: an overview, " Transplantation, vol. 91, no. 8, pp. 811-819, 2011.
85. F. Casiraghi, N. Azzollini, M. Todeschini, et al., "Localization of mesenchymal stromal cells dictates their immune or proinflammatory effects in kidney transplantation, " American Journal of Transplantation, vol. 12, no. 9, pp. 2373-2383, 2012.
86. M. Krampera, "Mesenchymal stromal cell licensing: a multistep process, " Leukemia, vol. 25, no. 9, pp. 1408-1414, 2011.
87. F. Casiraghi, N. Azzollini, P. Cassis, et al., "Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells, " Journal of Immunology, vol. 181, no. 6, pp. 3933-3946, 2008.
88. J. Y. Oh, M. K. Kim, J. H. Ko, H. J. Lee, J. H. Lee, and W. R. Wee, "Rat allogeneic mesenchymal stem cells did not prolong the survival of corneal xenograft in a pig-to-rat model, " Veterinary Ophthalmology, vol. 12, supplement 1, pp. 35-40, 2009.
89. S. Fuentes-Julian, F. Arnalich-Montiel, L. Jaumandreu, et al., "Adipose-derived mesenchymal stem cell administration does not improve corneal graft survival outcome, " PLoS ONE, vol. 10, no. 3, Article ID e0117945, 2015.
90. "The definition and classification of dry eye disease: report of the definition and classification Subcommittee of the International Dry Eye Workshop (2007), " The Ocular Surface, vol. 5, no. 2, pp. 75-92, 2007.
91. J. L. Gayton, "Etiology, prevalence, and treatment of dry eye disease, " ClinicalOphthalmology, vol. 3, no. 1, pp. 405-412, 2009.
92. Y. Ogawa and M. Kuwana, "Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation, " Cornea, vol. 22, no. 7, pp. S19-S27, 2003.
93. Y. Ogawa, S. Okamoto, M. Wakui, et al., "Dry eye after haematopoietic stem cell transplantation, " British Journal of Ophthalmology, vol. 83, no. 10, pp. 1125-1130, 1999.
94. M. E. Stern, C. S. Schaumburg, and S. C. Pflugfelder, "Dry eye as a mucosal autoimmune disease, " International Reviews of Immunology, vol. 32, no. 1, pp. 19-41, 2013.
95. W. Stevenson, S. K. Chauhan, and R. Dana, "Dry eye disease: an immune-mediated ocular surface disorder, " Archives of Ophthalmology, vol. 130, no. 1, pp. 90-100, 2012.
96. D. Zoukhri, "Mechanisms involved in injury and repair of the murine lacrimal gland: role of programmed cell death and mesenchymal stem cells, " Ocular Surface, vol. 8, no. 2, pp. 60-69, 2010.
97. D. Zoukhri, R. R. Hodges, D. Byon, and C. L. Kublin, "Role, of proinflammatory cytokines in the impaired lacrimation associated with autoimmune xerophthalmia, " Investigative Ophthalmology and Visual Science, vol. 43, no. 5, pp. 1429-1436, 2002.
98. E. Beyazyildiz, F. A. Pinarli, O. Beyazyildiz, et al., "Efficacy of topical mesenchymal stem cell therapy in the treatment of experimental dry eye syndrome model, " Stem Cells International, vol. 2014, Article ID 250230, 9 pages, 2014.
99. J. A. Wood, D.-J. Chung, S. A. Park, et al., "Periocular and intraarticular injection of canine adipose-derived mesenchymal stem cells: an in vivo imaging and migration study, " Journal of Ocular Pharmacology and Therapeutics, vol. 28, no. 3, pp. 307-317, 2012.
100. A. J. Villatoro, V. Fernandez, S. Claros, G. A. Rico-Llanos, J. Becerra, and J. A. Andrades, "Use of adipose-derived mesenchymal stem cells in keratoconjunctivitis sicca in a canine model, " BioMed Research International, vol. 2015, Article ID 527926, 10 pages, 2015.